GLOBUS MEDICAL INC Reports $763.7 million in Latest Quarterly Results
GLOBUS MEDICAL INC reported quarterly results highlighted by net sales for the third quarter of 2026 were $763.7 million, an as-reported decrease of 0.7% over t, according to its earnings release filed with an 8-K Thursday.
net income for the third quarter of 2026 was $141.2 million, an increase of 18.7% over the same peri. Base business sales (non-GAAP), excluding Nevro, were $690.0 million, an increase of 3.0%, as reported. earnings per share (“EPS”) was $1.04, an increase of 18.2%. Non-GAAP diluted EPS was $1.23, an increase of 4.
Results detail
Further figures in the release included Worldwide net sales were $763.7 million, a decrease of 0.7%, or a decrease of 0.5% on a constant currency basis; GAAP diluted earnings per share (“EPS”) was $1.04, an increase of 18.2%. Non-GAAP diluted EPS was $1.23, an increase of 4.4%; Worldwide net sales for the third quarter of 2026 were $763.7 million, an as-reported decrease of 0.7% over the third quarter of 2025. U.S. net sales for the third quarter of 2026 increased by 0.5% compared to the third quarter of 2025. International net sales decreased by 5.7% over the third quarter of 2025 on an as-reported basis and decreased by 5.0% on a constant currency basis.
The filing is an Item 2.02 results announcement furnished with Exhibit 99.1. Comparisons use the year-earlier period as presented by GLOBUS MEDICAL INC unless the release specifies another baseline. Where both GAAP and non-GAAP metrics appear, both are summarized when the extract includes them.
Segment mix, cash flow and any outlook language in the release are the usual secondary reads after the headline revenue and earnings figures.
Why it matters
For retail investors, the GLOBUS MEDICAL INC print is a check on whether growth, margins and cash generation are moving together. The figures above come from the company’s Exhibit 99.1 earnings materials; how they stack up against the prior-year run rate and any guide published with the release will shape the near-term debate.
By the numbers
- net sales for the third quarter of 2026 were $763.7 million, an as-reported decrease of 0.7% over t
- net income for the third quarter of 2026 was $141.2 million, an increase of 18.7% over the same peri
- Base business sales (non-GAAP), excluding Nevro, were $690.0 million, an increase of 3.0%, as reported.
- earnings per share (“EPS”) was $1.04, an increase of 18.2%. Non-GAAP diluted EPS was $1.23, an increase of 4
- Worldwide net sales were $763.7 million, a decrease of 0.7%, or a decrease of 0.5% on a constant currency basis.
- GAAP diluted earnings per share (“EPS”) was $1.04, an increase of 18.2%. Non-GAAP diluted EPS was $1.23, an increase of 4.4%.
Sources
- GLOBUS MEDICAL INC Form 8-K with quarterly financial results, filed Nov. 5, 2026 (accession 0001628280-26-071042)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.